Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

The growing utilisation of indwelling pleural catheters (IPCs) has put forward a new era in
the management of recurrent symptomatic pleural effusions. IPC use is safe compared to …

Background: This Guideline, a collaborative effort from the American Thoracic Society,
Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence …

Importance Indwelling pleural catheter and talc pleurodesis are established treatments for
malignant pleural effusions among patients with poor prognosis. Objective To determine …

Background Indwelling pleural catheters are an established management option for
malignant pleural effusion and have advantages over talc slurry pleurodesis. The optimal …

Background Many patients with lung cancer will develop symptoms related to their disease
process or the treatment they are receiving. These symptoms can be as debilitating as the …

Background Malignant pleural effusion (MPE) is a common complication of advanced
malignancy, but little is known regarding its prevalence and overall burden on a population …

Background Indwelling pleural catheters (IPCs) offer effective control of malignant pleural
effusions (MPEs). IPC-related infection is uncommon but remains a major concern …

Malignant pleural effusion (MPE) is a sign of advanced cancer and is associated with
significant symptom burden and mortality. To date, management has been palliative in …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …